Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

A Candidate Hypertension Gene

Will SPON1 Hold Salt and Water?

Scott Heximer, Mansoor Husain
Download PDF
https://doi.org/10.1161/01.RES.0000265134.57140.da
Circulation Research. 2007;100:940-942
Originally published April 12, 2007
Scott Heximer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mansoor Husain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • hypertension
  • genetics
  • animal models
  • vascular biology

See related article, pages 992–999

Hypertension affects >20% of the general population, and yet its etiologic basis remains unknown in the vast proportion of those affected.1 Hypertension greatly increases the risk of stroke, myocardial infarction, congestive heart failure and renal dysfunction thus making it an important focus of clinical research. Although pharmacological reductions in blood pressure have been shown to decrease the incidence of these adverse consequences,2 large numbers of hypertensive patients go undiagnosed, undertreated, or are nonresponsive to lifestyle modifications and medical therapy.1 As such, there remains a pressing need for an improved understanding of the mechanisms underlying hypertension.

Recent advances in genomic and proteomic analyses have led to the discovery of Mendelian forms (monogenetic traits) of hypertension.3,4 Although rare, these mutations which mainly involve altered renal salt handling, provide a molecular basis for understanding the critical role of the kidney during normal blood pressure regulation.5 By contrast, our understanding of the relative contributions of kidney, heart, CNS, and blood vessel function to blood pressure variations in the general population is complicated by the fact that spontaneous hypertension typically arises as a complex quantitative trait affected by differing combinations of genetic and environmental factors. A number of quantitative trait loci (QTL) associated with hypertension have been identified in both animal disease models and human patients, however the affected gene(s) at these sites have remained elusive owing to the large size and complexity of the regions identified.6 The use of congenic rodent strains to reduce the genomic size of QTLs is an important advance in the field (Reviewed in 7). Indeed, an article in this issue of Circulation Research highlights the potential of this strategy.8

Using this approach, Clemitson and colleagues have identified SPON1 as a novel candidate hypertension gene from within a region of rat chromosome 1 containing a blood pressure QTL.8 It may be of further relevance to human hypertension that a similar blood pressure QTL is found on the q arm of chromosome 1 in both rat and man.9,10 Previously, the Samani group identified a blood pressure QTL within chromosome 1 by combining phenotypic and genetic analyses of reciprocal intercrosses between SHR and WKY rat strains.11 Substrain analysis allowed dissection of the original blood pressure QTL region into smaller blood pressure QTL regions named BP1 and BP2.12 In the current study, a congenic SHR substrain containing WKY sequences at the BP1 QTL is bred against SHR (Figure, A) to reduce the genomic size of the WKY region to a point where targeted sequencing and expression profiling become feasible. The region identified contained 18 known and 3 novel genes. Following sequence and expression profile comparisons between numerous parental and congenic substrain combinations, the authors show that increased SPON1 mRNA and protein expression is consistently observed in animals from which BP1 genomic region is derived from the SHR rather than WKY strain. Accordingly, they contend that these studies warrant investigation of this gene as a novel positional candidate gene in the control of blood pressure in rats and humans (Figure, B).

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Dissection of a blood pressure QTL on rat chromosome 1 leads to identification of SPON1 as a novel candidate gene for hypertension. A, Shown is the breeding strategy used to reduce the size of the genomic region on chromosome 1 containing a blood pressure QTL. WKY-derived (black) sequences are shown on a SHR (white) genetic background. Recombination within the WKY-derived region produced 2 mutually exclusive congenic substrains, 1 of which showed differences in blood pressure regulation compared with SHR. Position of the candidate blood pressure regulation locus (shaded) is shown in relation to the original QTL and to WKY-derived sequences in the new congenic sub-strains. B, Expression profiling revealed increased expression of SPON1 and its gene product F-spondin in SHR- compared with WKY-derived sequences. It is hypothesized that the higher level of F-spondin produced from SHR-derived sequences affects developing kidneys, blood vessels, but possibly also other cardiovascular tissues to produce increased blood pressure levels.

The SPON1 gene product is F-spondin, the prototypical member of a group of nonthrombospondin members of the thrombospondin type I repeat (TSR) superfamily of proteins. It is a multifunctional protein containing 6 TSRs in its carboxyl terminus and 2 unique domains in its amino terminus. In the case of thrombospondin, the TSR domains can attract multiple different cells types through their ability to bind extracellular components including laminin, fibronectin, heparin, heparin sulfate proteoglycan, and CD36.13–16 In the case of the F-spondin TSR domains, the relevant extracellular binding partners have not been rigorously determined despite strong data supporting its role as an attachment factor for different cells.

F-spondin was originally identified as a candidate floor plate-derived adhesion protein that was highly expressed during development of the nervous system. Early work on this protein indicated that it could promote neurite attachment and outgrowth in the cultured spinal cord and sensory neurons.17 F-spondin is not highly expressed in adult nerve tissue, but it is highly expressed in developing17–19 and damaged nerve tissue leading to the hypothesis that upregulation of F-spondin promotes sensory nerve regeneration. The specific TSR domains that are required for this effect, and the extent to which F-spondin acts as an anchor protein relative to a trophic factor, remain to be established. It is tempting to speculate that F-spondin may also regulate sensory nerve guidance in the developing kidney or during pathophysiologic stress and that this may modulate kidney function.

The authors point to the interesting possibility that higher SPON1 expression in the vasculature of the developing kidneys contributes to the hypertensive phenotype in SHR rats, and that this may mediate strain-dependent morphological changes in the distal afferent arterioles.20 In support of the notion that F-spondin is involved in blood vessel development, F-spondin can promote vascular smooth muscle cell (VSMC) growth and exert antiangiogenic effects by inhibiting integrin signaling on endothelial cells.21 Alternatively, F-spondin may regulate blood pressure by direct modulation of VSMC signaling. Recent evidence suggests that the TSRs in the thrombospondin family prototype TSP-1 activate CD36 on the surface of VSMCs and endothelial cells to effect reduced NO-mediated accumulation of cGMP.22 If F-spondin TSRs had a similar inhibiting effect on NO-induced cGMP signaling, the attenuation of NO-mediated vasodilation may affect both renal and peripheral resistance vessels.

A more definitive strategy will be required to evaluate the functional significance of altered SPON1 expression. Organism-wide or tissue-specific transgenic strategies to overexpress or delete SPON1 will be required to evaluate whether simply changing its expression in the absence of additional genomic differences within the BP1 QTL is sufficient to modulate blood pressure in rats or mice. Such strategies will also provide the animal models in which more specific biological mechanisms underlying the pathogenesis of SPON1-related hypertension will need to be elucidated.

The current study represents a significant advance in the strategies used to identify positional candidate genes in QTLs for blood pressure and other physiologic traits. The absence of a molecular explanation for the observed increase in SPON1, however, raises the important question as to whether F-spondin is the sole contributor to the BP1 QTL. As we learn more about this interesting genomic region it will be important to rule out the possibility that one or more other gene products, splice variants or microRNAs originating from this same genomic region can also contribute to the blood pressure differences observed between these 2 rat strains. Ultimately, genomic sequencing of this entire QTL region from both strains will be helpful to rule out the contribution of other genomic components to the blood pressure phenotype, and to identify the molecular mechanism for increased SPON1 expression thus proving it is not simply a consequence of changes in pathophysiologic status of the kidneys or other tissues.

Acknowledgments

S.H. currently holds a Tier II Canada Research Chair in Cardiovascular Physiology and is supported by the Department of Physiology and the Heart and Stroke Richard Lewar Centre for Excellence in Cardiovascular Research, University of Toronto. M.H. currently holds a Career Investigator Award from the Heart and Stroke Foundation of Ontario (CI5503) and is supported by the Departments of Medicine, Physiology, Laboratory Medicine and Pathobiology and the Heart and Stroke Richard Lewar Centre for Excellence in Cardiovascular Research, University of Toronto.

Disclosures

None.

Footnotes

  • The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.

References

  1. ↵
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003; 289: 2560–2572.
    OpenUrlCrossRefPubMed
  2. ↵
    Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc. 2002; 288: 2981–2997.
    OpenUrlCrossRefPubMed
  3. ↵
    Nabel EG. Cardiovascular disease. N Engl J Med. 2003; 349: 60–72.
    OpenUrlCrossRefPubMed
  4. ↵
    Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet. 2003; 361: 1629–1641.
    OpenUrlCrossRefPubMed
  5. ↵
    Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001; 104: 545–556.
    OpenUrlCrossRefPubMed
  6. ↵
    Stoll M, Cowley AW Jr., Tonellato PJ, Greene AS, Kaldunski ML, Roman RJ, Dumas P, Schork NJ, Wang Z, Jacob HJ. A genomic-systems biology map for cardiovascular function. Science. 2001; 294: 1723–1726.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet. 2006; 7: 829–840.
    OpenUrlPubMed
  8. ↵
    Clemitson JR, Dixon RJ, Haines S, Bingham AJ, Patel BR, Hall L, Lo M, Sassard J, Charchar FJ, Samani NJ. Genetic dissection of a blood pressure quantitative trait locus on rat chromosome 1 and gene expression analysis identifies SPON1 as a novel candidate hypertension gene. Circ Res. 2007; 100: 992–999.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev. 2000; 80: 135–172.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Kotchen TA, Broeckel U, Grim CE, Hamet P, Jacob H, Kaldunski ML, Kotchen JM, Schork NJ, Tonellato PJ, Cowley AW Jr. Identification of hypertension-related QTLs in African American sib pairs. Hypertension. 2002; 40: 634–639.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Frantz SA, Kaiser M, Gardiner SM, Gauguier D, Vincent M, Thompson JR, Bennett T, Samani NJ. Successful isolation of a rat chromosome 1 blood pressure quantitative trait locus in reciprocal congenic strains. Hypertension. 1998; 32: 639–646.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Frantz S, Clemitson JR, Bihoreau MT, Gauguier D, Samani NJ. Genetic dissection of region around the Sa gene on rat chromosome 1: evidence for multiple loci affecting blood pressure. Hypertension. 2001; 38: 216–221.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol. 1986; 103: 1635–1648.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Bornstein P. Thrombospondins: structure and regulation of expression. Faseb J. 1992; 6: 3290–3299.
    OpenUrlAbstract
  15. ↵
    Roberts DD. Regulation of tumor growth and metastasis by thrombospondin-1. Faseb J. 1996; 10: 1183–1191.
    OpenUrlAbstract
  16. ↵
    Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, Bouck NP. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol. 1997; 138: 707–717.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Burstyn-Cohen T, Tzarfaty V, Frumkin A, Feinstein Y, Stoeckli E, Klar A. F-Spondin is required for accurate pathfinding of commissural axons at the floor plate. Neuron. 1999; 23: 233–246.
    OpenUrlCrossRefPubMed
  18. ↵
    Klar A, Baldassare M, Jessell TM. F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cell. 1992; 69: 95–110.
    OpenUrlCrossRefPubMed
  19. ↵
    Burstyn-Cohen T, Frumkin A, Xu YT, Scherer SS, Klar A. Accumulation of F-spondin in injured peripheral nerve promotes the outgrowth of sensory axons. J Neurosci. 1998; 18: 8875–8885.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Norrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MJ, Korsgaard N. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension. 1994; 24: 301–308.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Terai Y, Abe M, Miyamoto K, Koike M, Yamasaki M, Ueda M, Ueki M, Sato Y. Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin alphavbeta3 on vascular endothelial cells. J Cell Physiol. 2001; 188: 394–402.
    OpenUrlCrossRefPubMed
  22. ↵
    Isenberg JS, Wink DA, Roberts DD. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res. 2006; 71: 785–793.
    OpenUrlAbstract/FREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
April 13, 2007, Volume 100, Issue 7
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    A Candidate Hypertension Gene
    Scott Heximer and Mansoor Husain
    Circulation Research. 2007;100:940-942, originally published April 12, 2007
    https://doi.org/10.1161/01.RES.0000265134.57140.da

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    A Candidate Hypertension Gene
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    A Candidate Hypertension Gene
    Scott Heximer and Mansoor Husain
    Circulation Research. 2007;100:940-942, originally published April 12, 2007
    https://doi.org/10.1161/01.RES.0000265134.57140.da
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured